DK133813B - Fremgangsmade til fremstilling af 17alfa-propadienylsteroider - Google Patents

Fremgangsmade til fremstilling af 17alfa-propadienylsteroider

Info

Publication number
DK133813B
DK133813B DK195170A DK195170A DK133813B DK 133813 B DK133813 B DK 133813B DK 195170 A DK195170 A DK 195170A DK 195170 A DK195170 A DK 195170A DK 133813 B DK133813 B DK 133813B
Authority
DK
Denmark
Prior art keywords
17alfa
procedure
preparation
propadienyl
steroids
Prior art date
Application number
DK195170A
Other languages
English (en)
Other versions
DK133813C (da
Inventor
J A Edwards
Original Assignee
Syntex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Corp filed Critical Syntex Corp
Publication of DK133813B publication Critical patent/DK133813B/da
Application granted granted Critical
Publication of DK133813C publication Critical patent/DK133813C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
DK195170A 1969-04-18 1970-04-17 Fremgangsmade til fremstilling af 17alfa-propadienylsteroider DK133813C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81756369A 1969-04-18 1969-04-18
US87752169A 1969-11-17 1969-11-17

Publications (2)

Publication Number Publication Date
DK133813B true DK133813B (da) 1976-07-26
DK133813C DK133813C (da) 1976-12-13

Family

ID=27124181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK195170A DK133813C (da) 1969-04-18 1970-04-17 Fremgangsmade til fremstilling af 17alfa-propadienylsteroider

Country Status (15)

Country Link
JP (1) JPS4916857B1 (da)
AT (1) AT322120B (da)
BE (1) BE749067A (da)
CA (1) CA919167A (da)
CH (1) CH540894A (da)
DE (1) DE2018055B2 (da)
DK (1) DK133813C (da)
ES (1) ES378764A1 (da)
FI (1) FI47985C (da)
FR (1) FR2051496B1 (da)
GB (2) GB1310612A (da)
IL (2) IL34228A (da)
NL (1) NL7005604A (da)
NO (1) NO134553C (da)
SE (1) SE355802B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH571537A5 (da) * 1970-04-24 1976-01-15 Sandoz Ag
GB1348186A (en) * 1970-04-24 1974-03-13 Sandoz Ltd 17alpha-propadienyl steroids

Also Published As

Publication number Publication date
IL44105A0 (en) 1974-05-16
IL34228A (en) 1975-04-25
AT322120B (de) 1975-05-12
BE749067A (fr) 1970-10-01
JPS4916857B1 (da) 1974-04-25
DE2018055B2 (de) 1976-12-23
GB1310612A (en) 1973-03-21
NO134553B (da) 1976-07-26
FR2051496A1 (da) 1971-04-09
ES378764A1 (es) 1973-02-01
IL34228A0 (en) 1970-06-17
CH540894A (de) 1973-08-31
CA919167A (en) 1973-01-16
DE2018055A1 (de) 1970-10-22
FI47985C (fi) 1974-05-10
NL7005604A (da) 1970-10-20
GB1310611A (en) 1973-03-21
FI47985B (da) 1974-01-31
SE355802B (da) 1973-05-07
DK133813C (da) 1976-12-13
NO134553C (da) 1976-11-03
FR2051496B1 (da) 1973-03-16

Similar Documents

Publication Publication Date Title
DK146244C (da) Fremgangsmaade til fremstilling af cystingruppeholdige peptider
DK132228C (da) Fremgangsmade til fremstilling af ikke-cellulere polyurethaner
DK150981C (da) Fremgangsmaade til fremstilling af diesterdiamider
DK131628C (da) Fremgangsmade til fremstilling af tioninderivater
DK133741C (da) Analogifremgangsmade til fremstilling af indankarboxamidderivater
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
DK133279B (da) Analogifremgangsmade til fremstilling af phenylaminoethanolderivater
DK560675A (da) Fremgangsmade til fremstilling af thiopyrimidinderivater
DK132586C (da) Fremgangsmade til fremstilling af erythromycylaminer
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
DK133813B (da) Fremgangsmade til fremstilling af 17alfa-propadienylsteroider
DK131786C (da) Fremgangsmade til fremstilling af delta4-3-oxo-1alfa-methylsteroider
DK140551B (da) Fremgangsmaade til fremstilling af diazabicycloalkanderivater
DK127107B (da) Fremgangsmåde til fremstilling af 17α-propadienyl-17β-hydroxy-steroider.
DK131943C (da) Fremgangsmade til fremstilling af 17beta-oxalylsteroider
DK145932C (da) Fremgangsmaade til fremstilling af substituerede cobamider
DK122456B (da) Fremgangsmåde til fremstilling af quinoxalin-di-N-oxid-aldehyd.
DK132026C (da) Fremgangsmade til fremstilling af 6-aminoacylamidopenicillansyrer
DK132029C (da) Fremgangsmade til fremstilling af meldrojepeptidalkaloider
DK139577C (da) Fremgangsmaade til fremstilling af des-phenylalaninb1-insulin
DK133240C (da) Analogifremgangsmade til fremstilling af cyklopentylaminobutanolderivater
DK132790C (da) Fremgangsmade til fremstilling af nitrosodisulfonater
DK132953C (da) Fremgangsmade til fremstilling af formlegemer af polylactamer
DK132176C (da) Fremgangsmade til fremstilling af triorganoblyforbindelser
DK127108B (da) Fremgangsmåde til fremstilling af 9α-usubstituerede 11β-klor-19-nor-steroider.